PEAK6 Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-51,400
Closed -$6.12M 4271
2018
Q1
$6.12M Buy
51,400
+20,900
+69% +$2.69M 0.21% 704
2017
Q4
$3.88M Sell
30,500
-25,900
-46% -$3.25M 0.13% 958
2017
Q3
$6.63M Buy
+56,400
New +$4.81M 0.27% 601
2017
Q2
Sell
-13,800
Closed -$707K 4502
2017
Q1
$707K Sell
13,800
-2,800
-17% -$129K 0.04% 1964
2016
Q4
$622K Buy
16,600
+10,000
+152% +$419K 0.03% 2308
2016
Q3
$447K Sell
6,600
-4,800
-42% -$339K 0.02% 2430
2016
Q2
$633K Buy
11,400
+8,200
+256% +$517K 0.04% 2177
2016
Q1
$201K Buy
+3,200
New +$213K 0.02% 3121
2015
Q4
Sell
-400
Closed -$32K 4694
2015
Q3
$32K Sell
400
-8,300
-95% -$922K ﹤0.01% 4788
2015
Q2
$1.04M Sell
8,700
-40,000
-82% -$4.78M 0.04% 2046
2015
Q1
$5.08M Buy
48,700
+29,300
+151% +$2.97M 0.23% 673
2014
Q4
$1.88M Buy
19,400
+2,800
+17% +$259K 0.07% 1379
2014
Q3
$1.3M Buy
16,600
+10,000
+152% +$645K 0.04% 1600
2014
Q2
$417K Sell
6,600
-8,700
-57% -$517K 0.01% 2483
2014
Q1
$1.03M Buy
+15,300
New +$1.18M 0.03% 1845
2013
Q4
Sell
-212,600
Closed -$6.81M 4854
2013
Q3
$6.81M Buy
212,600
+165,700
+353% +$8.26M 0.18% 550
2013
Q2
$1.45K Buy
+46,900
New +$1.25M 0.01% 1823

Other funds holding ALNY